Summary: Henry Schein acquired Acentus, a CGM supplier with $35 million in annual revenue. The deal broadens Henry Schein’s national homecare solutions platform and is expected to be neutral to 2025 earnings per share. Founders of Acentus will join Henry Schein, reinforcing the company’s growing focus on the homecare market.
Key Takeaways:
- This acquisition expands Henry Schein’s homecare solutions footprint, particularly in CGM distribution for patients receiving care at home.
- The deal follows other homecare-focused acquisitions, boosting Henry Schein’s total homecare platform revenue to over $350 million.
Henry Schein has completed the acquisition of substantially all of the assets of Acentus, a national medical supplier specializing in the delivery of Continuous Glucose Monitors (CGMs).
Financial Details and Impact
Headquartered in Tampa, Fla, Acentus reported annual revenue of approximately $35 million. Henry Schein expects the transaction to be neutral to 2025 non-GAAP earnings per share and accretive thereafter. Financial terms were not disclosed.
Acentus founders Brett Carroll, Todd Cianfrocca, Greg Duvall, and Julio Valdivia will join Henry Schein as part of the deal.
RELATED: Servicing Dental Equipment
Strategic Expansion in Homecare Solutions
“Henry Schein continues to expand upon our national homecare solutions platform to effectively address the evolving needs of our customers, which includes clinics, physician practices, health systems, and patients receiving care at home,” said Stanley M. Bergman, chairman of the board and chief executive officer, Henry Schein. “The acquisition of Acentus represents an important step towards strengthening our position within the home medical supply market. By directly delivering CGM products to patients’ homes, we are enhancing our ability to serve our valued customers and drive growth.”
The Acentus transaction follows Henry Schein’s acquisition of Prism Medical Products, LLC in 2021 and Shield Healthcare and Mini Pharmacy in 2023, highlighting the company’s strategic commitment to the homecare medical supplies market. Henry Schein’s homecare medical products platform will now have an annual revenue base in excess of $350 million, according to the company.